Annual Meeting Sessions on Diversity, Equity, and Inclusion
As a global hematology community, ASH understands the importance of having individuals with diverse perspectives and experiences in all areas of the field and strives to improve the outcomes for individuals with hematologic diseases. Diversity, Equity, and Inclusion Sessions examine the science of how identity differences impact outcomes and how attendees can mitigate those differences to achieve equitable outcomes for all individuals with hematologic diseases and disorders.
For more information on ASH's efforts in the DEI space, please visit the ASH's DEI page.
Blood Journals Studio
Distinguished Abstract Achievement Award Ceremony
| Saturday, December7,2024,2:00p.m.-3:30p.m. San Diego Convention Center , Halls G-H - Blood Journals Studio |
This event will honor the research of this year's Distinguished Abstract Achievement Award winners, including our partnered awards and the Outstanding Abstract Achievement Award which recognizes the top scoring abstracts in each trainee category (undergraduate, graduate, medical student, resident, and post-doctoral fellow). This event will be moderated by Dr. Christopher Flowers.
The list of 2024 Winners are:
Yu Akahoshi
Hussein Awada
Francesca Cendali
Alejandro De Janon
Daisy Diaz Rohena
Enrica Federti
Mike Fernandez
Travis Fleming
Natalie Grover
Fernanda Gutierrez-Rodrigues
Amelia Haj
NaShea Kendrick
Kristopher Knight
Luca Lanino
Olivia Lightfuss
Shan Liu
Paola Manara
Alicia Matthews
Aneta Mikulasova
Adrian Minson
Toru Miyajima
Daniel Navarrete
Maria Feliz Norberto
Jenny Paredes
Alexandros Rampotas
Suruchi Salgar
Ruka Shimura
Samuel Urrutia
Joshua Wischmeyer
Casey Wong
Xuesen Zheng
back to topCompany Showcases
A New Era in Research: Pragmatic Prospective Real-World Studies
| Saturday, December7,2024,3:45p.m.-4:00p.m. San Diego Convention Center , Room 5A |
For in-person participants only
back to topѻý Program
A Little Less Conversation, a Little More Action: An Outcome Equity Roadmap for Children and AYAs With Leukemia and Lymphoma
| Saturday, December7,2024,9:30a.m.-10:
45a.m. Marriott Marquis San Diego Marina , Marriott Grand Ballroom 2-4 |
Centuries of structural racism have contributed to discrimination, environmental and social injustice, and household material hardship among historically marginalized populations. Recent studies have highlighted the impact of factors such as income and insurance status on cancer outcomes and health equity. Under-representation of specific groups has limited our understanding of cancer risk, disease biology, treatment-related toxicities, and patient-reported outcomes. The educational objective of this session is to present the latest evidence regarding modifiable factors that contribute to outcome disparities in childhood/adolescent and young adult (AYA) hematologic malignancies, and to discuss potential targets for interventions that address these disparities. Dr. Ji will present an in-depth overview of public health insurance programs in the U.S. and related implications on outcome disparities among AYAs with blood cancers. Using a case-based approach, Dr. Ji will discuss opportunities to improve access to high-quality public health insurance, subsequent to the Affordable Care Act. Dr. Umaretiya will discuss the role of social determinants of health (SDOH) as modifiable drivers of outcome inequities in pediatric oncology. She will review the prevalence of SDOH in pediatric oncology, present historically marginalized parent perspectives on unmet social needs during cancer care, and highlight novel interventions addressing this population’s SDOH and social needs. Dr. Mittal will discuss factors contributing to low rates of enrollment of AYAs with hematologic malignancies to clinical trials, including a lack of availability and accessibility. She will provide an up-to-date review of collaborative initiatives that are addressing some of these barriers to improve AYA access to cancer clinical trials.
Chair:
Maria MonicaGramatges,MD,PhD
Texas Children's Hospital
Houston,
TX
Speakers:
ݳ,ʳ
Emory University School of Medicine
Atlanta,
GA
The Lasting Impact of the ACA: How Medicaid Expansion Reduces Outcome Disparities in AYAs With Leukemia and Lymphoma
Puja J.Umaretiya,MD
Childrens Medical Center Dallas, UT Southwestern
Dallas,
TX
Targeting Hardship: Poverty as a Modifiable Risk Factor in Childhood Leukemia and Lymphoma Treatment
ܱܰѾٳٲ,ѵ
University Of Illinois At Chicago
Chicago,
IL
Sharing is Caring: A Network Collaborative Approach to Identify and Address Barriers in Accessing Clinical Trials in Adolescents and Young Adults with Leukemia and Lymphoma
Hematologic Management of the Patient with Heavy Menstrual Bleeding
| Saturday, December7,2024,2:00p.m.-3:15p.m. San Diego Convention Center , Room 28 A-D |
Heavy menstrual bleeding (HBM) has an important impact on the physical, emotional and social well-being, and in adolescents, can be the only clinical sign of an underlying bleeding disorder. Due to several medical, economic and social factors, it remains a significantly underdiagnosed and undertreated condition. Hematologists play an important role in the evaluation and care of patients with anemia from chronic blood loss, and may be the first clinicians to identify HMB as its cause. This education session will describe a clinical multidisciplinary approach to the evaluation and treatment of patients presenting with HMB, with a special focus on adolescents. It will provide an overview of diagnostic and management strategies to broaden the tools available to hematologists caring for these patients in different clinical settings.
Dr. Allison P Wheeler will discuss the various tools available for the quantification of menstrual blood loss, including those that evaluate the effect of HMB on quality of life; followed by a description of non-surgical (hormonal and non-hormonal) treatments of HMB, their efficacy, contraindications and selection of the most appropriate therapy using shared decision-making.
Dr. Juliana Perez Botero will present a focused approach to laboratory testing (screening and confirmatory) for patients presenting with HMB in whom von Willebrand Disease is suspected, with emphasis on the effect of pre-analytical variables and testing methodology on the results and their clinical interpretation.
Dr. Janice Staber will discuss the value of multidisciplinary clinics specializing in the care of adolescents with HMB, including their critical components and different care delivery models, and share important lessons learned during the development and implementation of one of these clinics.
Chair:
JulianaPerez Botero,MD
Mayo Clinic
Rochester,
MN
Speakers:
Allison PWheeler,MD/MSCI
Washington Center for Bleeding Disorders
Seattle,
WA
Quantifying Menorrhagia and Overview of Non-Surgical Management of Heavy Menstrual Bleeding
JulianaPerez Botero,MD
Mayo Clinic
Rochester,
MN
Von Willebrand Disease and Heavy Menstrual Bleeding: When and How to Test
Ծٲ,Ѷ
University of Iowa Stead Family Children's Hospital
Iowa City,
IA
Heavy Menstrual Bleeding Clinics for Adolescents
Sex Hormones, Contraceptives, and Thrombotic Risk: Where Are We Now?
| Monday, December9,2024,2:45p.m.-4:00p.m. San Diego Convention Center , Room 29 |
Venous thromboembolism is a common disease, with an incidence of one to three per 1000 individuals per year. Numerous risk factors are known, which can be divided into genetic and acquired. One of the most well-known acquired risk factors is exposure to endogenous (i.e. pregnancy) and exogenous female hormones, including oral contraceptive use, hormone substitution therapy, and gender-affirming hormone therapy. Thrombosis specialists are frequently consulted about optimal hormonal therapy in individuals with an increased risk of venous thromboembolism, as well as optimal management of pregnancy-related venous thromboembolism.
Dr Leslie Skeith will cover contraceptive-related VTE risk by agent and by clinical scenario, including in patients with inherited thrombophilia, systemic lupus erythematosus with or without antiphospholipid antibodies or antiphospholipid syndrome, and sickle cell disease considering contraception. Relevant clinical practice guidelines are reviewed. A multidisciplinary approach to counselling is needed for patient-focused decision-making.
Dr Joseph Shatzel will explore the hematologic complications of gender-affirming therapy, with a particular focus on managing and mitigating the thrombotic risks linked to exogenous estrogen use. He will detail existing data on thrombotic risks reported in transgender individuals and provide insights from studies involving cisgender women and men who receive exogenous estrogen and testosterone, providing important contextual background. He will delve into strategies for addressing testosterone-induced erythrocytosis and iron deficiency in transgender individuals undergoing hormone therapy.
Dr Saskia Middeldorp will present clinical cases of VTE related to hormonal contraceptive use and pregnancy to illustrate key considerations for clinical practice. Practice points for primary VTE treatment and the evidence on the risk of recurrent VTE and bleeding in this population are detailed. The potential value of thrombophilia testing is described including the: “who, why, when, what and how”. We also discuss key aspects of shared decision making for anticoagulant duration, including a reduced dose anticoagulant strategy in hormone-related VTE.
Chair:
SaskiaMiddeldorp,MD, PhD
Radboud university medical center
Nijmegen,
Netherlands
Speakers:
ٳ,Ѷ
University of Calgary
Calgary,
AB,Canada
Estrogen, Progestin, and Beyond: Thrombotic Risk and Contraceptive Choices
Joseph J.Shatzel,MD
Oregon Health and Science University
Portland,
OR
Gender-Affirming Hormone Therapy in the Transgender Patient: Influence on Thrombotic Risk
SaskiaMiddeldorp,MD, PhD
Radboud university medical center
Nijmegen,
Netherlands
Hormone-Related Thrombosis: Duration of Anticoagulation, Risk of Recurrence, and the Role of Hypercoagulability Testing
The Expanding Landscape of Treatment for ITP
| Saturday, December7,2024,9:30a.m.-10:
45a.m. San Diego Convention Center , Room 28 A-D |
The management of Immune Thrombocytopenia (ITP) has seen a renaissance in the available therapies and in the approach to patients with the diagnosis in recent years. This has lead to an expanding number of therapeutic options for patients and physicians to consider as they embark on their therapeutic journey with ITP. Dr. Waleed Ghanima will discuss the new approaches incorporating combination strategies in management of patients with ITP including suggestions for when to consider moving beyond mono therapy for ITP. Dr. Annemarie Fogerty will then discuss updates on ITP in pregnancy, a special category of ITP with implications for both maternal and fetal health and provide the most information on both treatments and outcomes. Finally, Dr. Michele Lambert will then describe current clinical trials (or recently completed) and provide information on novel therapeutics that are in development as well as the current treatment gaps where additional study is needed.
Chair:
Michele P.Lambert,MD
Children's Hospital of Philadelphia
Philadelphia,
PA
Speakers:
²ҳԾ,Ѷ,ʳ
Østfold Hospital
Gralum,
Norway
Insights on Treatment of Adult ITP: Algorithm for Management and Role of Multimodal Therapy
Annemarie EFogerty,M.D.
Massachusetts General Hospital
Boston,
MA
ITP in Pregnancy: Diagnostics and Therapeutics in 2024
Michele P.Lambert,MD
Children's Hospital of Philadelphia
Philadelphia,
PA
On the Horizon: Upcoming New Agents for the Management of ITP
Events
Poster Session I - Presentations (for in-person participants)
| Saturday, December7,2024,5:30p.m.-7:30p.m. San Diego Convention Center , Halls G-H |
Take the opportunity to speak face to face with authors at their posters! Gain insight into their work, ask questions, and enjoy snacks and refreshments.
back to topPoster Session I - Viewing
| Saturday, December7,2024,9:00a.m.-7:30p.m. San Diego Convention Center , Halls G-H |
Attendees are encouraged to browse posters on the virtual meeting platform via the poster flipbook and then walk the hall throughout the day to view them in person. Take yourself on a self-guided audio tour using the author's videos from the virtual meeting platform or PosterCast. Earbuds are available at the Poster Help Desk.
As a reminder, posters displayed in the hall today can only be viewed in-person today; digital versions of all posters will be available on the virtual meeting platform for the duration of the meeting until your virtual subscription expires.
back to topPoster Session II - Presentations (for in-person participants)
| Sunday, December8,2024,6:00p.m.-8:00p.m. San Diego Convention Center , Halls G-H |
Take the opportunity to speak face to face with authors at their posters! Gain insight into their work, ask questions, and enjoy snacks and refreshments.
back to topPoster Session II - Viewing
| Sunday, December8,2024,9:00a.m.-8:00p.m. San Diego Convention Center , Halls G-H |
Attendees are encouraged to browse posters on the virtual meeting platform via the poster flipbook and then walk the hall throughout the day to view them in person. Take yourself on a self-guided audio tour using the author's videos from the virtual meeting platform or PosterCast. Earbuds are available at the Poster Help Desk.
As a reminder, posters displayed in the hall today can only be viewed in-person today; digital versions of all posters will be available on the virtual meeting platform for the duration of the meeting until your virtual subscription expires.
back to topPoster Session III - Presentations (for in-person participants)
| Monday, December9,2024,6:00p.m.-8:00p.m. San Diego Convention Center , Halls G-H |
Take the opportunity to speak face to face with authors at their posters! Gain insight into their work, ask questions, and enjoy snacks and refreshments.
back to topPoster Session III - Viewing
| Monday, December9,2024,9:00a.m.-8:00p.m. San Diego Convention Center , Halls G-H |
Attendees are encouraged to browse posters on the virtual meeting platform via the poster flipbook and then walk the hall throughout the day to view them in person. Take yourself on a self-guided audio tour using the author's videos from the virtual meeting platform or PosterCast. Earbuds are available at the Poster Help Desk.
As a reminder, posters displayed in the hall today can only be viewed in-person today; digital versions of all posters will be available on the virtual meeting platform for the duration of the meeting until your virtual subscription expires.
back to topHealth Equity Studio
Achieving Equity and Inclusion in Clinical Trial Enrollment: Challenges and Opportunities
| Saturday, December7,2024 3:30..-4:00.. San Diego Convention Center , Sails Pavilion - ASH Health Equity Studio |
| Sunday, December8,2024 4:00..-4:30.. San Diego Convention Center , Sails Pavilion - ASH Health Equity Studio |
Dr. Paula Aristizabal will describe the role of Social Determinants of Health, such as health literacy and acculturation, in research participation, focused on marginalized communities. She will provide an overview of barriers and facilitators to achieving equity and inclusion in clinical trial enrollment, including her research implementing a culturally and linguistically tailored intervention to improve consent outcomes during enrollment for therapeutic clinical trials.
back to topAdvocating for Language Justice in Hematology
| Saturday, December7,2024 9:00..-9:30.. San Diego Convention Center , Sails Pavilion - ASH Health Equity Studio |
| Monday, December9,2024 12: 00p.m.-12: 30p.m. San Diego Convention Center , Sails Pavilion - ASH Health Equity Studio |
Dr. Joanna Robles addresses barriers to language appropriate care in hematology. She provides an overview of existing research of language disparities in research and clinical practice. She emphasizes practical strategies to advocate for language justice in hematology.
back to topCombating Structural Racism for Native Hawaiian and Other Pacific Islanders in Health Data
| Sunday, December8,2024 9:00..-9:30.. San Diego Convention Center , Sails Pavilion - ASH Health Equity Studio |
| Monday, December9,2024 8:15..-8:45.. San Diego Convention Center , Sails Pavilion - ASH Health Equity Studio |
Dr. Kekoa Taparra will highlight the importance of patient-centered care and examine how the erasure and aggregation of Native Hawaiian and Other Pacific Islander (NHPI) data perpetuates systemic racism in healthcare, leading to insufficient public policy and resource allocation for NHPI individuals. This session will advocate for inclusive data practices and strategies for improving data disaggregation and enhancing the visibility of NHPI health needs, which can help better address the disparities faced by this underserved community.
back to topEnsuring Equitable Access to Quality Care for Undocumented Immigrants and Mixed-Status Families
| Saturday, December7,2024 11: 00a.m.-11: 30a.m. San Diego Convention Center , Sails Pavilion - ASH Health Equity Studio |
| Monday, December9,2024 10: 00a.m.-10: 30a.m. San Diego Convention Center , Sails Pavilion - ASH Health Equity Studio |
Undocumented immigrants and mixed-status families face numerous structural barriers rooted in structural racism and xenophobia. Dr. Kemmick Pintor will discuss these structural barriers, the intersection of immigration and health care policy, and the resulting health and health care inequities. The session will provide examples of practices and policies to address these inequities and advance equity for undocumented immigrants and mixed-status families.
back to topGlobal Hematology Collaboration: Advancing Diversity and Leadership in Clinical Research
| Saturday, December7,2024 1:30..-2:00.. San Diego Convention Center , Sails Pavilion - ASH Health Equity Studio |
| Sunday, December8,2024 1:30..-2:00.. San Diego Convention Center , Sails Pavilion - ASH Health Equity Studio |
Dr. Luis Malpica shares his journey from Peru to global research leadership, and highlights strategies for fostering international collaborations in hematology research. He discusses the importance of increasing diversity in clinical trials and positioning physicians from minority backgrounds in leading high-impact research while mentoring the next generation of medical professionals to ensure equitable healthcare outcomes, globally.
back to topStrengthening the Provider-Patient Relationship: A Guide to Building Trust
| Sunday, December8,2024 11: 00a.m.-11: 30a.m. San Diego Convention Center , Sails Pavilion - ASH Health Equity Studio |
| Monday, December9,2024 1:00..-1:30.. San Diego Convention Center , Sails Pavilion - ASH Health Equity Studio |
Building trust between healthcare providers and systems with communities and patients is crucial for improving health outcomes and healing communities. Dr. Jorge Cortes and Dr. Randolph Lyde Jr. will discuss prioritizing open communication, empathy, and respect and how providers can foster a sense of partnership with patients and communities with the goal of achieving increased community buy-in,improved health outcomes, increase participation in clinical trials, and a stronger healthcare system.
back to topMarquee Sessions
2024 Ham-Wasserman Lecture
| Saturday, December7,2024,12:
30p.m.-1:30p.m. San Diego Convention Center , Hall B |
Sickle cell disease (SCD) is an inherited red blood cell (RBC) disorder caused by either homozygous inheritance of the hemoglobin S mutation (HbSS), or compound heterozygous inheritance of the hemoglobin S mutation with another ß-globin chain abnormality. India has among the highest hemoglobin S allele frequencies in the world and the third-highest birth rate for babies born with HbSS.
The Indian sickle cell haplotype is associated with the Arab-Indian or Asian haplotype and is associated with high fetal hemoglobin (HbF) levels and hence, is believed to have mild clinical presentation as compared to other populations.
In this lecture Dr. Dipty Jain will discuss the status of frequency, comorbidities, and management of sickle cell disease (SCD) in India, which is characterized by relatively high percentages of fetal hemoglobin, accompanied by mild to severe complications observed globally. Additionally she will talk about targeted newborn screening and fixed low dose of hydroxyurea in managing children with sickle cell disease in India.
Dr. Jain will discuss the milestones and progress in understanding sickle cell disease (SCD) phenotype accelerated by the Government of India’s ambitious ‘’National Sickle Cell Anemia Elimination Mission 2023’’ with comprehensive guidelines and implementation of screening, treat, counsel, educate, development of technology and novel therapies including gene therapy specific to the requirement of India’s population with sickle cell disease (SCD).
Chair:
MohandasNarla,DSc
New York Blood Center
New York,
NY
Speaker:
Dipty LalitJain,MD,MBBS
Government Medical College and Hospital, Nagpur
NAGPUR,
Maharastra,India
Sickle Cell Disease in Developing Countries
Special-Interest Sessions
DEI Community Networking Lunch (for in-person participants)
| Monday, December9,2024,12:
00p.m.-1:15p.m. Marriott Marquis San Diego Marina , Marina Ballroom D |
This is a community-building and networking event for members that fall within the diversity, equity, and inclusion (DEI) umbrella to gather and get to know each other across the varying and intersectional communities. This event is hosted by the Committee on Diversity, Equity, and Inclusion and aims to create space for ASH DEI communities and allies and, where possible, identify opportunities to learn more about the experiences and needs of these communities to allow ASH to have a greater impact in its DEI efforts. This year’s event will include inspiring remarks from a member of the committee and networking opportunities throughout.
back to topHealth Equity Rounds Lunch
| Sunday, December8,2024,11:
30a.m.-12:
30p.m. Manchester Grand Hyatt San Diego , Coronado Ballroom AB |
Health Equity Rounds are interactive, case-based discussions with an interdisciplinary panel to include hematologists, health equity/public health experts, patients, and patient advocates to discuss health equity issues within hematology. Lunch will be provided to in-person attendees.
CoChair:
Speakers:
Ash BlytheAlpert,MD, MFA
Yale School of Medicine
New Haven,
CT
Hematologic Aspects of Gender Affirming Care
Eric ScottMullins,MD
Cincinnati Children's Hospital Medical Center
Cincinnati,
OH
Hematologic Aspects of Gender Affirming Care
Health Equity Symposium: Race, Structural Racism and the Social Determinants of Health in Hematology
| Sunday, December8,2024,9:30a.m.-11:
00a.m. San Diego Convention Center , Room 6DE |
The misuse of race in medicine has far-reaching implications across practice, teaching, and research in hematology. This session is intended to explore what race is and what it is not, and illustrate how systemic factors, including racism, influence health care access and outcomes. The session will also explore strategies to tackle systemic racism in patient care and how to create conditions for equitable care for patients with blood diseases. Dr. Joseph L. Graves Jr. will provide a summary of the history of biological conceptions of race and describe modern evolutionary conceptions of race. He will then address how this understanding can be useful in employing the power of modern genomic tools applied to human biological diversity, including how the use of these tools completely unravels the false premises of racial medicine. Dr. Chanita Hughes Halbert will define health care disparities and describe the nature and distribution of social determinants of disparities in disease risk and outcomes. She will also provide an overview of structural racism and its impact on health care outcomes in diverse populations.
Chair:
Deirdra RTerrell,PhD
University of Oklahoma Health Sciences Center
Oklahoma City,
OK
Speakers:
Joseph LGraves Jr.,PhD
North Carolina A&T State University
Greensboro,
NC
The Myth of Race in Medical Science
Chanita HughesHalbert,PhD
University of Southern California
Los Angeles,
CA
Structural Racism, the Social Determinants of Health, and Healthcare Outcomes – Understanding Inequity and What to Do About It
Hematology Inclusion Pathway (HIP) Networking Reception
| Saturday, December7,2024,8:00p.m.-9:00p.m. Marriott Marquis San Diego Marina , Marina Ballroom G |
Join our HIP community to network and celebrate our awardees and their mentors at this reception following the oral presentations.
back to topHematology Inclusion Pathway (HIP) Oral Presentations - Classical Hematology
| Saturday, December7,2024,6:00p.m.-9:00p.m. Marriott Marquis San Diego Marina , Marina Ballroom E |
The Hematology Inclusion Pathway Presentations and Reception (previously known as Promoting Minorities in Hematology); ASH invites all interested meeting attendees to this event, which will showcase the research of our Hematology Inclusion Pathway awardees. This initiative is a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in. The highlight of the session will be oral scientific presentations from program participants.
Speakers:
ValeriaBrown
The Warren Alpert Medical School of Brown University
Providence,
RI
Investigating the Role of Long Interspersed Element-1 (LINE-1) in Age-Related Clonal Hematopoiesis of Indeterminate Potential (CHIP) Driven By JAK2 V617F Mutation
Esther ChiomaEmenalom
University of California, San Diego
San Diego,
CA
A Study of Postpartum Hemorrhage and a Cryoprecipitate Intervention at Hospital Central De Maputo
Maria FernandaAlbuja Altamirano,MD
Lincoln General Hospital
New York,
NY
Incidence of Thrombotic and Bleeding Complications in Patients with Cancer Undergoing Lower Extremity Arthroplasty, an Administrative Database Study
AshleyCrosby,MD
Atrium Health Wake Forest Baptist Medical Center
Winston Salem,
NC
Monocyte Distribution Width As a Marker of Red Cell Alloimmunization
Ayotola A.Fatola,MD
Johns Hopkins University School of Medicine
Baltimore,
MD
Evaluating the Role of Voxelotor and Percent Modified Hemoglobin (Hemoglobin X) on Laboratory and Clinical Responses in Patients with Sickle Cell Disease
OlisaemekaOgbue,MBBS
Cleveland Clinic Foundation
Rocky River,
OH
Can Emergency Hematopoiesis Due to Sepsis Lead to Clonal Hematopoiesis? Implications for Understanding the Pathogenesis of Clonal Evolution
MariaFeliz Norberto,MS
Albert Einstein College of Medicine
Bronx,
NY
Heterozygous DDX41 Mutations Promote Age-Dependent Hematopoietic Stem and Progenitor Dysfunction
Conroy OField,MS
The University of Pennsylvania School of Medicine
Philadelphia,
PA
Role of Platelet Factor 4 in the Prothrombotic Nature of Antiphospholipid Syndrome
SarahMansour
Emory University
Atlanta,
GA
Methionine Sulfoxide and Other Metabolites from Bronchoalveolar Lavage Are Associated with Neutrophil-Dominated Lung Disease in Early Cystic Fibrosis
Olufunke Y.Martin,MD
Children's National Hospital
Washington DC,
DC
The Role of Red Blood Cell Vascular Adhesion Biomarkers in Understanding Sickle Cell Disease-Associated Chronic Pain
Walatta-TseyonMesquitta,BSc,DPhil
Boston Children's Hospital
Boston,
MA
Interrogating TCF15 Function in Native Hematopoiesis Using TCF15 Overexpression and Conditional Knock out Mouse Models
Hematology Inclusion Pathway (HIP) Oral Presentations - Health Services Outcomes
| Saturday, December7,2024,6:00p.m.-9:00p.m. Marriott Marquis San Diego Marina , Marina Ballroom F |
The Hematology Inclusion Pathway Presentations and Reception (previously known as Promoting Minorities in Hematology); ASH invites all interested meeting attendees to this event, which will showcase the research of our Hematology Inclusion Pathway awardees. This initiative is a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in. The highlight of the session will be oral scientific presentations from program participants.
Speakers:
EmilyFranco,BA
The Warren Alpert Medical School of Brown University
Davie,
FL
Exploring Mental Health in Sickle Cell Disease: Implementing Routine Psychological Assessment in a Comprehensive Sickle Cell Clinic
RachelleMonteau
CUNY School of Medicine
New York,
NY
Outcomes of Adult ALL/LBL Patients from Diverse Backgrounds Treated in the United States between 2000 and 2022
Osariemen VioletOgiamien,MD, BS
University of California Riverside Science Library
Riverside,
CA
Neighborhood Socioeconomic/Environmental Disadvantage and Health Outcomes after Allogeneic Hematopoietic Cell Transplantation
MargaritaVazquez Almonte
SUNY Upstate Medical University
Bronx,
NY
Parenthood While in Hematology: Perceived Barriers
DanielGoyco Vera,MD
Baylor College of Medicine
Houston,
TX
Outcomes of Patients Underrepresented in Pivotal Trials of CAR-T Cell Therapy
MichelleNwachukwu,DO
University of Illinois at Chicago
Chicago,
IL
The Impact of Structural Racism on Molecular Subtypes and Survival Outcomes in Acute Myeloid Leukemia Patients
Ifeanyi NnamdiUche,MBBS
One Brookdale University Hospital and Medical Center
Brooklyn,
NY
Examining the Impact of Body Mass Index on Outcomes in Young Adults with Sickle Cell Disease: A Single-Center Study
BritneyBell,MD
Section of Hematology and Medical Oncology, Boston Medical Center
Boston,
MA
Integration of Health Literacy Universal Precautions into Clinical Practice as a Strategy to Improve Patient-Reported Outcomes in Patients with Hematologic Malignancies and Limited English Proficiency
Eden AyeleBiltibo,MD,MS
Vanderbilt University Medical Center
Nashville,
TN
Impact of Daratumumab in the Treatment of Vulnerable Transplant Eligible Multiple Myeloma Patients and Its Utilization in Blacks
GerardHills,MD
Riley Hospital for Children at Indiana University Health
Indianapolis,
IN
A Step Toward Individualized Mortality Risk Prediction in Patients with Sickle Cell Disease in a National EHR-Derived Population Dataset
AlexandraPower-Hays,MD
Cincinnati Children's Hospital Medical Center
Cincinnati,
OH
Alternative Dosing and Prevention of Transfusions (ADAPT): A Prospective Trial to Quantify the Change in Blood Transfusion Use with Hydroxyurea Treatment and the Feasibility of Pharmacokinetic-Guided Dosing in Children with Sickle Cell Anemia in Uganda
Hematology Inclusion Pathway (HIP) Oral Presentations - Malignant Hematology
| Saturday, December7,2024,6:00p.m.-9:00p.m. Marriott Marquis San Diego Marina , Marina Ballroom D |
The Hematology Inclusion Pathway Presentations and Reception (previously known as Promoting Minorities in Hematology); ASH invites all interested meeting attendees to this event, which will showcase the research of our Hematology Inclusion Pathway awardees. This initiative is a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in. The highlight of the session will be oral scientific presentations from program participants.
Speakers:
John Roy RLozada,MD
University of Minnesota
Minneapolis,
MN
An Integrated Systems Biology Approach to Understanding the Phenotypic and Functional Diversity of Natural Killer Cells in Cancer
Sofia E.Luna
Leland Stanford Stanford Junior University
Stanford,
CA
Engineering Hematopoietic Stem Cells to Generate Therapeutic Antibody Secreting B Cells
FathimaMohamed
University of Minnesota
Minneapolis,
MN
Metabolic Regulation of the Germinal Center Reaction in Chronic Graft Versus Host Disease
Andres JRubio,MS
Texas Tech University Health Sciences Center El Paso Paul L. Foster School of Medicine
El Paso,
TX
A Role for PSMD3 in Regulating Oxidative Energy Metabolism in Acute Myeloid Leukemia (AML)
CatherineGutierrez,MD, PhD
Massachusetts General Hospital
Boston,
MA
Identifying Mechanisms of Resistance to ATR Inhibition in Myelodysplastic Syndromes with Splicing Factor Mutations
KellyMeza,MD
Baylor College of Medicine
Houston,
TX
Retrospective Analysis of the PET/CT Imaging Features of Peripheral T-Cell Lymphoma (PTCL) and Cutaneous T-Cell Lymphoma (CTCL) Patients
JoaneTitus,MD, MS
University of Central Florida
Orlando,
FL
Retrospective Review of Care for Black/African American Veterans with Multiple Myeloma at the Orlando VA
KalayBertulfo,MS,MA,MPhil
Columbia University Irving Medical Center
New York,
NY
Therapeutic Targeting of JAK/STAT Signaling and Histone Acetyltransferase Activity in Post-Myeloproliferative Neoplasm Secondary AML
QuentonBubb,MPhil
Leland Stanford Junior University
Stanford,
CA
Development of Multivalent Cell Therapies for Treatment of Hematologic Malignancies
JoiceKanefsky
Fox Chase Cancer Center
Philadelphia,
PA
Disruption of Polyunsaturated Fatty Acid Biosynthesis Drives Sting-Dependent Acute Myeloid Leukemia Cell Maturation and Death
Kristopher AdrianKnight
Emory University
Atlanta,
GA
Development of a Novel L-Asparaginase with Enhanced Properties Using Ancestral Sequence Reconstruction
OwhofasaAgbedia
MD Anderson Cancer Center
houston,
TX
Targeting Aggressive NK-Cell Leukemia and Other CD94-Expressing NK/T-Cell Lymphoproliferative Disorders with CAR T-Cell Therapy
LGBTQIA+ Community Networking Brunch (for in-person participants)
| Sunday, December8,2024,11:
00a.m.-12:
30p.m. Manchester Grand Hyatt San Diego , Coronado DE |
This is a community-building and networking event for members of the LGBTQIA+ community attending the meeting. The event is hosted by the Committee on Diversity, Equity, and Inclusion and aims to create a sense of belonging and allyship. This year’s event will include an insightful panel discussion focused on being LGBTQIA+ across the hematology career spectrum, including the role of mentorship and the importance of inclusivity, as well as ample networking opportunities.
back to topMedical Educators Symposium
| Sunday, December8,2024,7:30a.m.-9:30a.m. Marriott Marquis San Diego Marina , Marina Ballroom FG |
The Medical Educators Symposium (previously called the Hematology Course Directors Workshop) is open to all medical educators across the medical student, resident, and fellow continuum. The Medical Educators Symposium highlights cutting edge teaching techniques and theories while also showcasing participants of the ASH Medical Educators Institute. The symposium is two hours long and will begin with an hour of general sessions focused on medical education principles and then followed by simultaneous breakout sessions that happen twice.
Chair:
Hetty E.Carraway,MD,MBA
Cleveland Clinic
Cleveland,
OH
Speakers:
Alison WLoren,MD
University of Pennsylvania
Philadelphia,
PA
General Session 1: Paving a Career in Medical ѻý & Scholarship
Megan MurrayDupuis,MD, PhD
Vanderbilt University Medical Center
Nashville,
TN
General Session 2: Utilizing Humanities to Influence and Tailor Hematology Curriculum for Adult Learners
Layla NVan Doren,MD, MBA
Yale University
New York,
NY
General Session 3: Incorporating Health Equity ѻý in UME/GME Curriculum
Alexander ABoucher,MD
University of Minnesota
Minneapolis,
MN
General Session 3: Incorporating Health Equity ѻý in UME/GME Curriculum
BeverlySchaefer,MD
University of Buffalo
Buffalo,
NY
Breakout 1: Challenges of Course Development
Ariela L.Marshall,MD
University of Minnesota
Rochester,
MN
Breakout 2: Developing Your Teaching Portfolio
Jason AFreed,MD
Beth Israel Deaconess
Boston,
MA
Breakout 3: Cutting-Edge Technology in ѻý Delivery
Thomas W.LeBlanc,MD,MA,MS
Duke Cancer Institute
Hillsborough,
NC
Breakout 4: Developing a Palliative Care/Difficult Discussion Curriculum
Race and Ancestry in Precision Medicine
| Sunday, December8,2024,4:30p.m.-5:45p.m. San Diego Convention Center , Room 6DE |
Race and ancestry, historically, have been poorly considered in basic and translational research design and clinical diagnoses. This session will describe how race and ancestry can inform hematology research conduct, specifically in clinical and genetic population profiling, interpretation of common hematologic tests, development of diagnostics, and overall precision medicine. The speakers selected in this session have incorporated race and ancestry in their own research and will be sharing their insights to help educate hematology investigators and clinicians understand how to consider race and ancestry into their own research and practice.
Dr. Fox will discuss the intersection between human population genetics, biomedicine, ancient genomics, and Indigenous data sovereignty. This talk will provide perspectives on why community consultation matters in genomics research and in the establishment of benefit-sharing models.
Dr. Eisfeld will discuss race-associated differences in the mutational landscape and the prognostic significance of molecular markers in acute myeloid leukemia (AML) in Black patients. This talk will highlight the need for refinement of disease classification and molecular subtypes to enable personalized risk-stratification and treatment options for racially diverse populations.
Dr. Achebe has led the hematology community in incorporating Duffy-null status into clinical algorithms to improve health equity for Duffy-null individuals among Black and African American adults. This talk will highlight how inappropriate blood count reference ranges can propagate systemic racism.
CoChair:
Speakers:
KeoluFox
University of California, San Diego
San Diego,
CA
Incorporating Indigenous Perspectives into Population Genetics
Ann-KathrinEisfeld,MD
The Ohio State University
Columbus,
OH
Risk Re-Stratification Based on Black AML Patient Exome Data
Maureen OkamAchebe,MD,MPH
Brigham and Women's Hospital
Boston,
MA
How Inappropriate Reference Ranges Can Propagate Systemic Racism
Sickle Cell Disease Centers Session
| Sunday, December8,2024,9:30a.m.-11:
00a.m. San Diego Convention Center , Room 33 |
To ensure high-quality care for patients with sickle cell disease (SCD), it is imperative that providers and SCD care leaders have the tools to establish comprehensive clinical care centers for patients with SCD. Over the last several years, ASH has developed a program and blueprint for the creation of sickle cell disease centers. This special interest session is designed to help sickle cell disease care centers understand the development of CMS quality metrics and how to leverage these metrics to support delivery of high-quality care.
CoChair:
Speakers:
AlexandraPower-Hays,MD
Cincinnati Children's Hospital
Cincinnati,
OH
The Importance of Recognition of Pediatric Quality Metrics in SCD: The Role of US News and World Report
TitilopeFasipe,MD,PhD
Texas Children's Cancer and Hematology Centers
Houston,
TX
The Creation of CMS Quality Metrics in the Treatment of Painful Episodes in the Emergency Department
CeceliaCalhoun,MD,MBA,MPH
Yale New Haven Hospital
New Haven,
CT
Leveraging Quality Metrics to Maintain Support of Your Sickle Cell Disease Center
Symposium on Quality: Treating Fairly - The Role of Quality Improvement in Combating Health Care Disparities
| Saturday, December7,2024,2:00p.m.-3:30p.m. San Diego Convention Center , Room 11 |
This year's Quality Symposium will focus on practical strategies for combatting healthcare disparities. First, Dr. Melissa Creary will discuss the Michigan Social Health Interventions to Eliminate Disparities (MSHIELD) program, a statewide data-driven, community-partnered, and equity-centered quality improvement effort. Then Dr. Michelle Sholzberg will review the development and impact of the "Raise the Bar" project, which aims to eliminate disparities in the recognition and management of iron deficiency by adjusting reference ranges. The session will conclude with a talk by Dr. Thomas Greg Knight on mitigating the impact of financial toxicity in patients with hematologic malignancies.
CoChair:
Speakers:
MelissaCreary
University of Michigan School of Public Health
Ann Arbor,
MI
MSHIELD: A Statewide Approach to Improving Equity Centered Quality Improvement
MichelleSholzberg,MDCM, MSc
University of Toronto
Toronto,
ON,Canada
Raise the Bar - Combatting Disparities in the Recognition and Management of Iron Deficiency
Thomas G.Knight,MD
Atrium Health
Charlotte,
NC
Cancer and Poverty - Mitigating the Impact of Financial Toxicity in Patients with Hematologic Malignancies
Women In Hematology Networking Event (for in-person participants)
| Monday, December9,2024,7:30p.m.-9:30p.m. Manchester Grand Hyatt San Diego , Coronado Ballroom and Terrace |
This popular annual networking event will provide a space where all can gather and connect with peers and potential mentors. The event includes a panel discussion focused on work life integration through a gender and career development lens. Hors d'oeuvres will be provided before and after the panel, along with desserts after the panel.
Spotlight Sessions
Biology Underlying Disparities in Lymphoid Malignancies
| Sunday, December8,2024,4:30p.m.-5:45p.m. Marriott Marquis San Diego Marina , Pacific Ballroom Salons 18-19 |
This session will focus on uncovering how disparities in lymphoid cancers may be influenced by both the tumor microenvironment and genetic sequencing. By examining different types of lymphomas, the speakers will highlight how biological and genetic factors contribute to the disparities observed in Hodgkin lymphoma, multiple myeloma, and non-Hodgkin lymphoma for specific populations. This session aims to provide a comprehensive understanding of how these factors interact and shape treatment responses, survival rates, and disease progression, offering insights into reducing healthcare inequities. Together, these presentations will underscore the importance of a multifaceted approach—encompassing both the tumor environment and genetic profiling—to tackling disparities in lymphoma treatment and outcomes.
Dr. Cozen will discuss the critical role the tumor microenvironment plays in influencing disease outcomes, specifically focusing on how immune cells, stromal cells, and signaling molecules create conditions that vary across multiethnic cohorts. The presentation will explore how these variations may contribute to the disparities seen in survival and treatment response in both Hodgkin lymphoma and multiple myeloma. She will also present recent findings that suggest the microenvironment's interaction with genetic and socioeconomic factors, shaping future approaches for research and interventions for these populations.
Dr. Flowers will delve into the role of tumor sequencing in identifying genetic mutations and biomarkers that may be disproportionately prevalent across ancestry groups. The presentation will also discuss the relationships between genomic data and disease phenotypes that can be modeled and may impact treatment efficacy and outcomes. He will discuss the implications of these findings for precision medicine, including the need for more inclusive genetic research to better understand and address these disparities.
CoChair:
Speakers:
WendyCozen,DO, MPH
UCI, School of Medicine
Orange,
CA
Tumor Microenvironment Profiling to Investigate Disparities in Hodgkin Lymphoma and Multiple Myeloma
Christopher R.Flowers,MD, MS
The University of Texas MD Anderson Cancer Center
Houston,
TX
Tumor Sequencing to Investigate Disparities in Non-Hodgkin Lymphoma
Curative Therapies for Sickle Cell Disease: Option for Some but Not Quite All
| Sunday, December8,2024,4:30p.m.-5:45p.m. San Diego Convention Center , Room 30 |
Despite substantial improvements in care, individuals with sickle cell disease continue to experience substantial morbidity and a shortened life expectancy.With recent advances in the development of curative therapies, including allogeneic stem cell transplantation and gene therapy, it is important to identify barriers to accessing these treatments and adequately define suitable candidates for curative therapies.
In this session, Dr. Santosh Saraf will review the current guidelines for curative therapies, discuss the potential benefits and risks of the different curative therapies, and provide insight on when to refer patients for curative therapy.
In the second presentation, Dr. Payal Desai will discuss the various barriers to accessing curative therapies as well as the need for development of an integrated care approach.
Chair:
PayalDesai,MD
Atrium Health
Charlotte,
NC
Speakers:
Santosh L.Saraf,MD
University of Illinois Chicago
Chicago,
IL
Curative Therapies in Sickle Cell Disease: Which Patient, What Modality, and When to Refer
PayalDesai,MD
Wake Forest University
Charlotte,
NC
Systemic Barriers to Curative Therapy and Need for Integrated Care
Making a Match: Optimal Donor HLA and Beyond
| Monday, December9,2024,10:
30a.m.-11:
45a.m. San Diego Convention Center , Room 24 |
Selection of the optimal donor for allogeneic hematopoietic cell transplantation (allo-HCT) involves a comprehensive evaluation of several critical factors. Human leukocyte antigen (HLA) matching has proved to be the most likely crucial parameter in this process. However, several additional criteria can significantly influence allo-HCT outcomes.
Dr. Heather Stefanski will discuss the patient’s likelihood and probability of having a fully HLA-matched donor and finding a suitable donor prior to allo-HCT. She will summarize the historical barriers to transplant, especially for racially and ethnically diverse patients. A special focus will be put on new strategies, including post-transplant cyclophosphamide and abatacept, which can allow for safe and effective use of HLA-mismatched donor sources such as haploidentical donors and mismatched unrelated donors. Dr. Stefanski will highlight the research evidence that shows alternative donors are a viable and safe option for many allo-HCT recipients.
Dr. Mohamad Mohty will discuss the non-HLA factors which can contribute to further optimizing the selection of a donor prior to allo-HCT. These factors include the age of the donor (especially data favoring younger donors), recipient-donor gender mismatch and its impact on graft-versus-host disease, cytomegalovirus serostatus, and blood type compatibility. Dr Mohty will also briefly discuss the potential role of killer immunoglobulin-like receptor (KIR) matching, and donor-recipient kinship.
By integrating HLA and non-HLA variables into the donor selection process, one can significantly enhance the outcome of patients who are candidates for allo-HCT.
Chair:
MohamadMohty,MD,PhD
Saint-Antoine Hospital
Paris,
France
Speakers:
Heather E.Stefanski,MD,PhD
CIBMTR® (Center for International Blood and Marrow Transplant Research), NMDP
Minneapolis,
MN
HLA: Optimizing the ’Full HLA Match’
MohamadMohty,MD,PhD
Saint-Antoine Hospital
Paris,
France
Beyond HLA: Optimizing Non-HLA Variables
Trainee Activities and Services
Blood Buddies: Diversity, Equity, and Inclusion
| Wednesday, December6,2024,1:30p.m.-3:50p.m. Gaslamp Quarter , Café Sevilla Restaurant |
Trainees have the opportunity to meet with leaders in the field. Trainees sign up for a one-on-one Blood Buddy ten-minute mentoring session with a faculty member. Blood Buddies are experts in various hematology topic areas. This is an excellent opportunity for trainees to network with and receive mentorship from seasoned faculty. There are 3 Blood Buddies sessions at the event. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Buddies. The featured topics are: Adult Clinical Malignant Hematology; Pediatric Clinical Malignant Hematology; Adult Clinical Classical Hematology; Pediatric Clinical Classical Hematology; BMT Pediatric and Adult; Quality Improvement; Medical ѻý; PhD/Laboratory; Diversity, Equity, and Inclusion; International Medical Graduates; Future of Hematology (Artificial Intelligence); Industry Career Pathway; Federal Career Pathway.
back to topBlood Buddies: Pediatric Clinical Classical Hematology
| Wednesday, December6,2024,1:30p.m.-3:50p.m. Gaslamp Quarter , Café Sevilla Restaurant |
Trainees have the opportunity to meet with leaders in the field. Trainees sign up for a one-on-one Blood Buddy ten-minute mentoring session with a faculty member. Blood Buddies are experts in various hematology topic areas. This is an excellent opportunity for trainees to network with and receive mentorship from seasoned faculty. There are 3 Blood Buddies sessions at the event. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Buddies. The featured topics are: Adult Clinical Malignant Hematology; Pediatric Clinical Malignant Hematology; Adult Clinical Classical Hematology; Pediatric Clinical Classical Hematology; BMT Pediatric and Adult; Quality Improvement; Medical ѻý; PhD/Laboratory; Diversity, Equity, and Inclusion; International Medical Graduates; Future of Hematology (Artificial Intelligence); Industry Career Pathway; Federal Career Pathway.
back to topBlood Drop: Diversity, Equity, and Inclusion
| Wednesday, December6,2024 1:30p.m.-1:40p.m. Gaslamp Quarter , Station 9 |
| Wednesday, December6,2024 1:50p.m.-2:00p.m. Gaslamp Quarter , Station 9 |
The Blood Drop sessions are five to ten-minute presentations designed to provide short bursts of learning. Each micro learning session will be held twice in a row and will allow the audience to move on to their next topic of interest. Blood Drops are blocks of topic-driven breakout sessions that occur three times throughout the event. They focus on a variety of areas such as disease-specific and career development topics, as well as ASH opportunities for trainees. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Drops. The featured topics are: Malignant Hematology; Sickle Cell Disease; Career Development and Job Searching; Wellness; PhD; Clinical Research and Training Institute (CRTI); Translational Research Training in Hematology (TRTH); and Medical Educators Institute (MEI); Research Training Award for Fellows (RTAF); Scholar Award; and ASH-Harold Amos Medical Faculty Development Program (AMFDP) Award; Medical Student Physician-Scientist (Phy-Sci) Award; ASH Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award; and ASH Hematology Inclusion Pathway Medical Student Award; Diversity, Equity, and Inclusion; ASH Advocacy; International Medical Graduates; Career Pathway: Industry & Community; and Career Pathway: Federal Agencies.
Speaker:
NareshBumma,MD
The Ohio State University Comprehensive Cancer Center
COLUMBUS,
OH
Diversity, Equity, and Inclusion
Blood Drop: Diversity, Equity, and Inclusion
| Wednesday, December6,2024 3:20p.m.-3:30p.m. Gaslamp Quarter , Station 9 |
| Wednesday, December6,2024 3:40p.m.-3:50p.m. Gaslamp Quarter , Station 9 |
The Blood Drop sessions are five to ten-minute presentations designed to provide short bursts of learning. Each micro learning session will be held twice in a row and will allow the audience to move on to their next topic of interest. Blood Drops are blocks of topic-driven breakout sessions that occur three times throughout the event. They focus on a variety of areas such as disease-specific and career development topics, as well as ASH opportunities for trainees. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Drops. The featured topics are: Malignant Hematology; Sickle Cell Disease; Career Development and Job Searching; Wellness; PhD; Clinical Research and Training Institute (CRTI); Translational Research Training in Hematology (TRTH); and Medical Educators Institute (MEI); Research Training Award for Fellows (RTAF); Scholar Award; and ASH-Harold Amos Medical Faculty Development Program (AMFDP) Award; Medical Student Physician-Scientist (Phy-Sci) Award; ASH Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award; and ASH Hematology Inclusion Pathway Medical Student Award; Diversity, Equity, and Inclusion; ASH Advocacy; International Medical Graduates; Career Pathway: Industry & Community; and Career Pathway: Federal Agencies.
Speaker:
Julie EChang,MD
University of Wisconsin
Madison,
WI
Diversity, Equity, and Inclusion
Blood Drop: Diversity, Equity, and Inclusion
| Wednesday, December6,2024 2:40p.m.-2:50p.m. Gaslamp Quarter , Station 9 |
| Wednesday, December6,2024 3:00p.m.-3:10p.m. Gaslamp Quarter , Station 9 |
The Blood Drop sessions are five to ten-minute presentations designed to provide short bursts of learning. Each micro learning session will be held twice in a row and will allow the audience to move on to their next topic of interest. Blood Drops are blocks of topic-driven breakout sessions that occur three times throughout the event. They focus on a variety of areas such as disease-specific and career development topics, as well as ASH opportunities for trainees. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Drops. The featured topics are: Malignant Hematology; Sickle Cell Disease; Career Development and Job Searching; Wellness; PhD; Clinical Research and Training Institute (CRTI); Translational Research Training in Hematology (TRTH); and Medical Educators Institute (MEI); Research Training Award for Fellows (RTAF); Scholar Award; and ASH-Harold Amos Medical Faculty Development Program (AMFDP) Award; Medical Student Physician-Scientist (Phy-Sci) Award; ASH Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award; and ASH Hematology Inclusion Pathway Medical Student Award; Diversity, Equity, and Inclusion; ASH Advocacy; International Medical Graduates; Career Pathway: Industry & Community; and Career Pathway: Federal Agencies.
Speaker:
SrinivasDevarakonda,MD
The Ohio State University
Columbus,
OH
Diversity, Equity, and Inclusion
Blood Drop: International Medical Graduates
| Wednesday, December6,2024 2:40p.m.-2:50p.m. Gaslamp Quarter , Station 11 |
| Wednesday, December6,2024 3:00p.m.-3:10p.m. Gaslamp Quarter , Station 11 |
The Blood Drop sessions are five to ten-minute presentations designed to provide short bursts of learning. Each micro learning session will be held twice in a row and will allow the audience to move on to their next topic of interest. Blood Drops are blocks of topic-driven breakout sessions that occur three times throughout the event. They focus on a variety of areas such as disease-specific and career development topics, as well as ASH opportunities for trainees. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Drops. The featured topics are: Malignant Hematology; Sickle Cell Disease; Career Development and Job Searching; Wellness; PhD; Clinical Research and Training Institute (CRTI); Translational Research Training in Hematology (TRTH); and Medical Educators Institute (MEI); Research Training Award for Fellows (RTAF); Scholar Award; and ASH-Harold Amos Medical Faculty Development Program (AMFDP) Award; Medical Student Physician-Scientist (Phy-Sci) Award; ASH Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award; and ASH Hematology Inclusion Pathway Medical Student Award; Diversity, Equity, and Inclusion; ASH Advocacy; International Medical Graduates; Career Pathway: Industry & Community; and Career Pathway: Federal Agencies.
Speaker:
NarendranathEpperla,MD,MS
The Ohio State University
Columbus,
OH
International Medical Graduates
Blood Drop: International Medical Graduates
| Wednesday, December6,2024 3:20p.m.-3:30p.m. Gaslamp Quarter , Station 11 |
| Wednesday, December6,2024 3:40p.m.-3:50p.m. Gaslamp Quarter , Station 11 |
The Blood Drop sessions are five to ten-minute presentations designed to provide short bursts of learning. Each micro learning session will be held twice in a row and will allow the audience to move on to their next topic of interest. Blood Drops are blocks of topic-driven breakout sessions that occur three times throughout the event. They focus on a variety of areas such as disease-specific and career development topics, as well as ASH opportunities for trainees. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Drops. The featured topics are: Malignant Hematology; Sickle Cell Disease; Career Development and Job Searching; Wellness; PhD; Clinical Research and Training Institute (CRTI); Translational Research Training in Hematology (TRTH); and Medical Educators Institute (MEI); Research Training Award for Fellows (RTAF); Scholar Award; and ASH-Harold Amos Medical Faculty Development Program (AMFDP) Award; Medical Student Physician-Scientist (Phy-Sci) Award; ASH Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award; and ASH Hematology Inclusion Pathway Medical Student Award; Diversity, Equity, and Inclusion; ASH Advocacy; International Medical Graduates; Career Pathway: Industry & Community; and Career Pathway: Federal Agencies.
Speaker:
Nizar J.Bahlis,MD
Arnie Charbonneau Cancer Institute, University of Calgary
Calgary,
AB,Canada
International Medical Graduates
Blood Drop: International Medical Graduates
| Wednesday, December6,2024 1:30p.m.-1:40p.m. Gaslamp Quarter , Station 11 |
| Wednesday, December6,2024 1:50p.m.-2:00p.m. Gaslamp Quarter , Station 11 |
The Blood Drop sessions are five to ten-minute presentations designed to provide short bursts of learning. Each micro learning session will be held twice in a row and will allow the audience to move on to their next topic of interest. Blood Drops are blocks of topic-driven breakout sessions that occur three times throughout the event. They focus on a variety of areas such as disease-specific and career development topics, as well as ASH opportunities for trainees. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Drops. The featured topics are: Malignant Hematology; Sickle Cell Disease; Career Development and Job Searching; Wellness; PhD; Clinical Research and Training Institute (CRTI); Translational Research Training in Hematology (TRTH); and Medical Educators Institute (MEI); Research Training Award for Fellows (RTAF); Scholar Award; and ASH-Harold Amos Medical Faculty Development Program (AMFDP) Award; Medical Student Physician-Scientist (Phy-Sci) Award; ASH Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award; and ASH Hematology Inclusion Pathway Medical Student Award; Diversity, Equity, and Inclusion; ASH Advocacy; International Medical Graduates; Career Pathway: Industry & Community; and Career Pathway: Federal Agencies.
Speaker:
AditiShastri,MD
Montefiore Medical Center
Bronx,
NY
International Medical Graduates
Blood Drop: Sickle Cell Disease
| Wednesday, December6,2024 1:30p.m.-1:40p.m. Gaslamp Quarter , Station 2 |
| Wednesday, December6,2024 1:50p.m.-2:00p.m. Gaslamp Quarter , Station 2 |
The Blood Drop sessions are five to ten-minute presentations designed to provide short bursts of learning. Each micro learning session will be held twice in a row and will allow the audience to move on to their next topic of interest. Blood Drops are blocks of topic-driven breakout sessions that occur three times throughout the event. They focus on a variety of areas such as disease-specific and career development topics, as well as ASH opportunities for trainees. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Drops. The featured topics are: Malignant Hematology; Sickle Cell Disease; Career Development and Job Searching; Wellness; PhD; Clinical Research and Training Institute (CRTI); Translational Research Training in Hematology (TRTH); and Medical Educators Institute (MEI); Research Training Award for Fellows (RTAF); Scholar Award; and ASH-Harold Amos Medical Faculty Development Program (AMFDP) Award; Medical Student Physician-Scientist (Phy-Sci) Award; ASH Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award; and ASH Hematology Inclusion Pathway Medical Student Award; Diversity, Equity, and Inclusion; ASH Advocacy; International Medical Graduates; Career Pathway: Industry & Community; and Career Pathway: Federal Agencies.
Speaker:
DanielBauer
Harvard University
Boston,
MA
Sickle Cell Disease
Blood Drop: Sickle Cell Disease
| Wednesday, December6,2024 3:20p.m.-3:30p.m. Gaslamp Quarter , Station 2 |
| Wednesday, December6,2024 3:40p.m.-3:50p.m. Gaslamp Quarter , Station 2 |
The Blood Drop sessions are five to ten-minute presentations designed to provide short bursts of learning. Each micro learning session will be held twice in a row and will allow the audience to move on to their next topic of interest. Blood Drops are blocks of topic-driven breakout sessions that occur three times throughout the event. They focus on a variety of areas such as disease-specific and career development topics, as well as ASH opportunities for trainees. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Drops. The featured topics are: Malignant Hematology; Sickle Cell Disease; Career Development and Job Searching; Wellness; PhD; Clinical Research and Training Institute (CRTI); Translational Research Training in Hematology (TRTH); and Medical Educators Institute (MEI); Research Training Award for Fellows (RTAF); Scholar Award; and ASH-Harold Amos Medical Faculty Development Program (AMFDP) Award; Medical Student Physician-Scientist (Phy-Sci) Award; ASH Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award; and ASH Hematology Inclusion Pathway Medical Student Award; Diversity, Equity, and Inclusion; ASH Advocacy; International Medical Graduates; Career Pathway: Industry & Community; and Career Pathway: Federal Agencies.
Speaker:
John JStrouse,MD, PhD
Duke University School of Medicine
Durham,
NC
Sickle Cell Disease
Career Development Lunch
| Saturday, December7,2024,11:
15a.m.-12:
15p.m. Manchester Grand Hyatt San Diego , Coronado Ballroom |
This session provides an intimate venue for trainees to meet with leaders in hematology to discuss careers in the wide array of practice areas within hematology, including basic, clinical, and translational research, PhD careers, careers in industry settings, and careers in private and clinical practice. There will are multiple tables dedicated to each career area and one faculty member at each table leading the discussion. A boxed lunch is provided. This is a first come, first served event that is usually very-well attended. The full list of topics covered are: Adult BMT; Pediatric BMT; Adult Clinical Malignant Hematology; Adult Clinical Classical Hematology; Clinical Careers in Hematology (Private Practice Careers); Government Careers (NIH and FDA); Industry Careers; Laboratory and Translational Hematology; Medical Educators in Hematology; Pediatric Clinical Hematology; PhD careers; Systems-Based Hematology; Global Hematology; Maternal Health; Medical Informatics and AI; Lifespan; and Geriatric Hematology.
Chair:
Leidy L.Isenalumhe,MD, MS
Moffitt Cancer Center
Lutz,
FL
Yvonne A.Efebera,MD
Ohio Health
Columbus,
OH
Speakers:
Rakhi P.Naik,MD
Johns Hopkins Hospital
Baltimore,
MD
Hematology-Focused Fellowship Training Program (HFFTP)
RobertStern
Dana-Farber Cancer Institute, Inc.
Boston,
MA
Hematology-Focused Fellowship Training Program (HFFTP)
PallawiTorka,MD
Roswell Park Comprehensive Cancer Center
Buffalo,
NY
International Graduate Hematology
ShrutiChaturvedi,MBBS
Johns Hopkins University School of Medicine
Baltimore,
MD
International Graduate Hematology
TanyaWildes
University of Nebraska
Omaha,
NE
Geriatric Hematology
Alexander ABoucher,MD
University of Minnesota
Minneapolis,
MN
Lifespan Hematology
Matthew J.Maurer,DSc
Mayo University
Rochester,
MN
Medical Informatics and AI
LarsBullinger
University of Ulm
Berlin,
Germany
Medical Informatics & AI
PaulaJames,MD, FRCPC
Queen's University
Kingston,
ON,Canada
Maternal Health
AliBazarbachi,MD, PhD
American University of Beirut Medical Center
Beirut,
Lebanon
International Opportunities Hematology
KoheiHosokawa,MD, PhD
Kanazawa University
Kanazawa,
Japan
International Opportunities Hematology
VishalKukreti,MD,MSc
University Health Network
Toronto,
ON,Canada
Systems Based Hematology
ShannonElf,PhD
The University of Chicago
Chicago,
IL
PhD Careers
ParvathiRanganathan,PHD
Ohio State University
Columbus,
OH
PhD Careers
SaraVesely,PhD
The Univ. of OK Health Sciences Ctr.
Oklahoma City,
OK
Pediatric Clinical Hematology
Angela CWeyand,MD
University of Michigan Medical School
Ann Arbor,
MI
Pediatric Clinical Hematology
AndrewVolk,PhD
Cincinnati Children's Hospital Medical Center
Cincinnati,
OH
Laboratory and Translational Hematology
SanjayMohan,MD
Vanderbilt University Medical Center
Nashville,
TN
Medical Educators in Hematology
Tapan M.Kadia,MD
MD Anderson Cancer Center
Houston,
TX
Medical Educators in Hematology
Randal JosephWestrick,PhD
Oakland University
Rochester,
MI
Laboratory and Translational Hematology
DanielleTownsley
Astra Zeneca
Potomac,
MD
Industry Careers
E. Leila JeromeClay,MD
Johns Hopkins
Watertown,
MA
Industry Careers
Julie A.Panepinto,MD
Division of Blood Diseases and Resources, National Heart, Lung and Blood Institute
Bethesda,
MD
Government Careers (NIH and FDA)
CaraRabik,MD,PhD
Food and Drug Administration
Silver Spring,
MD
Government Careers (NIH and FDA)
EmilySaul
Columbus Oncology and Hematology
Columbus,
OH
Private Practice Hematology
MariaCarter Febres,MD
Cincinnati Children's Hospital
Cincinnati,
OH
Pediatric Hematology
Alfred ILee,MD, PhD
Yale University School of Medicine
New Haven,
CT
Adult Classical Hematology
PayalDesai,MD
Wake Forest University
Charlotte,
NC
Adult Classical Hematology
HannyAl-Samkari,MD
Massachusetts General Hospital, Harvard Medical School
Boston,
MA
Adult Classical Hematology
Basem M.William,MD, MRCP(UK), FACP
OhioHealth
Columbus,
OH
Adult Malignant Hematology
Sarah A.Wall,MD,MPH
The Ohio State University
Columbus,
OH
Adult Malignant Hematology
Abdullah MohammadKhan,MD, MBBS
The Ohio State University
Columbus,
OH
Adult BMT/Cellular Therapy
NareshBumma,MD
The Ohio State University Comprehensive Cancer Center
COLUMBUS,
OH
Adult BMT/Cellular Therapy
Monique A.Hartley-Brown,MD
DFCI
Boston,
MA
Adult BMT/Cellular Therapy
SajadKhazal
MD Anderson Medical Center
Loma Linda,
TX
Pediatric BMT/CAR-T
Mikkael A.Sekeres,MD
University of Miami Miller School of Medicine
Miami,
FL
Adult Malignant Hematology
OyebimpeAdesina,MD,MS
UC Davis Comprehensive Cancer Center
Sacramento,
CA
Adult Classical Hematology
YiZheng,PhD
Cincinnati Children's Hospital Medical Center
Cincinnati,
OH
Pediatric Hematology
StevenFein,MD,MPH
University of Miami
Miami,
FL
Private Practice Hematology
Elaine S.Jaffe,MD
National Cancer Institute, National Institute of Health
Bethesda,
MD
Government Careers (NIH and FDA)
MariaChaudhry
Bristol Myers Squibb
Madison,
NJ
Industry Careers
Alisa SWolberg,PhD
University of North Carolina at Chapel Hill
Chapel Hill,
NC
Laboratory and Translational Hematology
SandhyaPanch
National Institutes of Health
Seattle,
WA
Medical Educators in Hematology
Sarah H.O'Brien,MD,MSc
Ohio State University
Columbus,
OH
Pediatric Clinical Hematology
MargaretGoodell,PhD
Center for Cell and Gene Therapy, Baylor College of Medicine
Houston,
TX
PhD Careers
AshokPai,MD
Kaiser Permanente
Oakland,
CA
Systems Based Hematology
EbruKoca
Baskent University
Ankara,
Turkey
International Opportunities Hematology
LisaBaumann Kreuziger,MD,MS
Versiti
Milwaukee,
WI
Maternal Health
James S.Blachly,MD
The Ohio State University
Columbus,
OH
Medical Informatics & AI
RebeccaKruse-Jarres,MD,MPH
University of Washington
Seattle,
WA
Lifespan Hematology
AshleyRosko,MD
The Ohio State University
Columbus,
OH
Geriatric Hematology
SrikanthNagalla
Baptist Health South Florida
Miami,
FL
International Graduate Hematology
Hearts of Hematology (HoH)
| Wednesday, December6,2024,3:00p.m.-3:50p.m. Gaslamp Quarter , Hasta Mañana Cantina |
Hearts of Hematology captures the humanistic side of hematology/hematology-oncology through a collection of personalized short stories and other artistic pieces. This year we will kick-off HoH by showcasing seven stories representing a wide range of topics and diverse group of individuals. This gathering will include a few of the authors. Trainees from all levels and backgrounds are welcomed to join in this safe space for an opportunity to reflect on their experiences and bring the community closer.
back to topPlenary Session: ASH Talk #2 International Medical Graduates
| Wednesday, December6,2024,2:10p.m.-2:30p.m. Gaslamp Quarter , Main Stage |
The ASH Talk sessions are 20-minute presentations, similar to a TED Talk, with dynamic speakers presenting timely topics. ASH Talks are the core plenary sessions of ASH-a-Palooza that take place at the top of each hour. The talks contain little to no slides and draw the entire audience of ASH-a-Palooza together, between the other microlearning and networking sessions that occur throughout the event (Blood Drops and Blood Buddies).
Chair:
Kaitlyn CDykes,MD,BS
University of California San Diego
La Jolla,
CA
Speaker:
Jane SHankins,MD,MS
St. Jude Children's Research Hospital
Memphis,
TN
International Medical Graduates
66th ASH Annual Meeting and exposition
Registration for ASH members, non-members, groups, exhibitors, and media is now open!